BMC Nephrology (May 2006)

Gitelman-like syndrome after cisplatin therapy: a case report and literature review

  • Selhi Sharmila,
  • Angulo-Pernett Freddy,
  • Panichpisal Kessarin,
  • Nugent Kenneth M

DOI
https://doi.org/10.1186/1471-2369-7-10
Journal volume & issue
Vol. 7, no. 1
p. 10

Abstract

Read online

Abstract Background Cisplatin is a well-known nephrotoxic antineoplastic drug. Chronic hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria is one of the rare complications associated with its use. Case presentation A 42- year-old woman presented with a 20 year-history of hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria after cisplatin-based chemotherapy for ovarian cancer. This patient has had chronic muscle aches and fatigue and has had episodic seizure-like activity and periodic paralysis. Only thirteen other patients with similar electrolyte abnormalities have been described in the literature. This case has the longest follow-up. Conclusion Cisplatin can cause permanent nephrotoxicity, including Gitelman-like syndrome. This drug should be considered among the possible causes of chronic unexplained electrolyte disorders.